Acute effects of casein on postprandial lipemia and incretin responses in type 2 diabetic subjects

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 2, 2010, Pages 101-109

  Brader, L ^a   Holm, L ^a   Mortensen, L ^a   Thomsen, C ^a   Astrup, A ^b   Holst, J J ^c   de Vrese, M ^d   Schrezenmeir, J ^d   Hermansen, K ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

Author keywords

Casein; Incretins; Islet hormones; Postprandial period; Triglyceride; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL MARKER; CASEIN; CHYLOMICRON; DRUG DERIVATIVE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INCRETIN; INSULIN; RETINOL; RETINOL PALMITATE; TRIACYLGLYCEROL;

AGED; ARTICLE; BLOOD; CARBOHYDRATE DIET; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; TIME;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASEINS; CHYLOMICRONS; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; FEMALE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; INCRETINS; INSULIN; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; TIME FACTORS; TRIGLYCERIDES; VITAMIN A;

EID: 75349108421     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.03.019     Document Type: Article

References (31)

1. Rivellese A.A., De N.C., Di M.L., Patti L., Iovine C., Coppola S., et al. Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels. J Clin Endocrinol Metab 89 5 (2004 May) 2153-2159
2. Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation 60 3 (1979 Sep) 473-485
3. Proctor S.D., and Mamo J.C. Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall-evidence that plaque cholesterol may be derived from post-prandial lipoproteins. Eur J Clin Invest 28 6 (1998 Jun) 497-503
4. Karpe F., Steiner G., Uffelman K., Olivecrona T., and Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106 1 (1994 Mar) 83-97
5. Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., and Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298 3 (2007 Jul 18) 309-316
6. Nordestgaard B.G., Benn M., Schnohr P., and Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298 3 (2007 Jul 18) 299-308
7. Thomsen C., Rasmussen O., Lousen T., Holst J.J., Fenselau S., Schrezenmeir J., et al. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr 69 6 (1999 Jun) 1135-1143
8. Thomsen C., Storm H., Holst J.J., and Hermansen K. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes. Am J Clin Nutr 77 3 (2003 Mar) 605-611
9. Jeppesen J., Chen Y.D., Zhou M.Y., Wang T., and Reaven G.M. Effect of variations in oral fat and carbohydrate load on postprandial lipemia. Am J Clin Nutr 62 6 (1995 Dec) 1201-1205
10. Sullivan J.F. The effect of protein ingestion on alimentary lipemia. Am J Med Sci 243 (1962 Jun) 770-774
11. Gannon M.C., Nuttall F.Q., Saeed A., Jordan K., and Hoover H. An increase in dietary protein improves the blood glucose response in persons with type 2 diabetes. Am J Clin Nutr 78 4 (2003 Oct) 734-741
12. Holst J.J., and Orskov C. Incretin hormones - an update. Scand J Clin Lab Invest Suppl 234 (2001) 75-85
13. Meier J.J., Gethmann A., Gotze O., Gallwitz B., Holst J.J., Schmidt W.E., et al. Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans. Diabetologia 49 3 (2006 Mar) 452-458
14. Blomhoff R., Green M.H., Green J.B., Berg T., and Norum K.R. Vitamin A metabolism: new perspectives on absorption, transport, and storage. Physiol Rev 71 4 (1991 Oct) 951-990
15. Krarup T., Madsbad S., Moody A.J., Regeur L., Faber O.K., Holst J.J., et al. Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics. J Clin Endocrinol Metab 56 6 (1983 Jun) 1306-1312
16. Hvidberg A., Nielsen M.T., Hilsted J., Orskov C., and Holst J.J. Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man. Metabolism 43 1 (1994 Jan) 104-108
17. Holst J.J. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. Biochem J 207 3 (1982 Dec 1) 381-388
18. Schrezenmeir J., Weber P., Probst R., Biesalski H.K., Luley C., Prellwitz W., et al. Postprandial pattern of triglyceride-rich lipoprotein in normal-weight humans after an oral lipid load: exaggerated triglycerides and altered insulin response in some subjects. Ann Nutr Metab 36 4 (1992) 186-196
19. Carstensen M., Thomsen C., and Hermansen K. Incremental area under response curve more accurately describes the triglyceride response to an oral fat load in both healthy and type 2 diabetic subjects. Metabolism 52 8 (2003 Aug) 1034-1037
20. Cohen J.C. Protein ingestion does not affect postprandial lipaemia or chylomicron-triglyceride clearance. Eur J Clin Nutr 43 7 (1989 Jul) 497-499
21. Westphal S., Kastner S., Taneva E., Leodolter A., Dierkes J., and Luley C. Postprandial lipid and carbohydrate responses after the ingestion of a casein-enriched mixed meal. Am J Clin Nutr 80 2 (2004 Aug) 284-290
22. Westphal S., Taneva E., Kastner S., Martens-Lobenhoffer J., Bode-Boger S., Kropf S., et al. Endothelial dysfunction induced by postprandial lipemia is neutralized by addition of proteins to the fatty meal. Atherosclerosis 185 2 (2006 Apr) 313-319
23. Gannon M.C., Nuttall F.Q., Lane J.T., and Burmeister L.A. Metabolic response to cottage cheese or egg white protein, with or without glucose, in type II diabetic subjects. Metabolism 41 10 (1992 Oct) 1137-1145
24. Dalgaard M., Thomsen C., Rasmussen B.M., Holst J.J., and Hermansen K. Ethanol with a mixed meal decreases the incretin levels early postprandially and increases postprandial lipemia in type 2 diabetic patients. Metabolism 53 1 (2004 Jan) 77-83
25. Kolovou G.D., Anagnostopoulou K.K., Salpea K.D., Daskalopoulou S.S., and Mikhailidis D.P. The effect of statins on postprandial lipemia. Curr Drug Targets 8 4 (2007 Apr) 551-560
26. Nilsson M., Stenberg M., Frid A.H., Holst J.J., and Bjorck I.M. Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Am J Clin Nutr 80 5 (2004 Nov) 1246-1253
27. Nordt T.K., Besenthal I., Eggstein M., and Jakober B. Influence of breakfasts with different nutrient contents on glucose, C peptide, insulin, glucagon, triglycerides, and GIP in non-insulin-dependent diabetics. Am J Clin Nutr 53 1 (1991 Jan) 155-160
28. Holst J.J., and Gromada J. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol Endocrinol Metab 287 2 (2004 Aug) E199-E206
29. Vilsboll T., Krarup T., Sonne J., Madsbad S., Volund A., Juul A.G., et al. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 88 6 (2003 Jun) 2706-2713
30. Linn T., Santosa B., Gronemeyer D., Aygen S., Scholz N., Busch M., et al. Effect of long-term dietary protein intake on glucose metabolism in humans. Diabetologia 43 10 (2000 Oct) 1257-1265
31. Dolais-Kitabgi J., and Freychet P. Neurotensin inhibits glucose but not glucagon-induced insulin and somatostatin release in isolated islets. Diabete Metab 5 4 (1979 Dec) 275-277